Oncology Hematology West - Methodist — Omaha, Nebraska

Oncology Hematology West - Methodist is a clinical research site located in Omaha, Nebraska, United States 68114.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Oncology Hematology West - Methodist has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Triple Negative Breast Cancer.

Sponsors: Gilead Sciences.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Oncology Hematology West - Methodist?

Oncology Hematology West - Methodist has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Oncology Hematology West - Methodist conducted?

Oncology Hematology West - Methodist has 1 clinical trials on record, with 1 currently active. Their work covers Triple Negative Breast Cancer.

Is Oncology Hematology West - Methodist accredited by Crixeo Health?

Oncology Hematology West - Methodist has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Oncology Hematology West - Methodist?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.